These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 19083534)
1. Nonsurgical reshaping of the lower face. Liew S; Dart A Aesthet Surg J; 2008; 28(3):251-7. PubMed ID: 19083534 [TBL] [Abstract][Full Text] [Related]
2. Abobotulinum toxin A and onabotulinum toxin A for masseteric hypertrophy: a split-face study in 25 Korean patients. Lee SH; Wee SH; Kim HJ; Yeo UC; Lee NH; Lee SW; Cho SB J Dermatolog Treat; 2013 Apr; 24(2):133-6. PubMed ID: 21888570 [TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects. Quezada-Gaon N; Wortsman X; PeƱaloza O; Carrasco JE J Cosmet Dermatol; 2016 Sep; 15(3):238-44. PubMed ID: 26799545 [TBL] [Abstract][Full Text] [Related]
4. The use of botulinum toxin type A in aesthetic mandibular contouring. Kim NH; Chung JH; Park RH; Park JB Plast Reconstr Surg; 2005 Mar; 115(3):919-30. PubMed ID: 15731696 [TBL] [Abstract][Full Text] [Related]
5. Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy. Arikan OK; Tan FU; Kendi T; Koc C J Otolaryngol; 2006 Feb; 35(1):40-3. PubMed ID: 16527016 [TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin for masseter reduction in Asian patients. Ahn J; Horn C; Blitzer A Arch Facial Plast Surg; 2004; 6(3):188-91. PubMed ID: 15148129 [TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin for masseter hypertrophy. Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335 [TBL] [Abstract][Full Text] [Related]
13. Effects of botulinum toxin type A on contouring of the lower face. Choe SW; Cho WI; Lee CK; Seo SJ Dermatol Surg; 2005 May; 31(5):502-7; discussion 507-8. PubMed ID: 15962731 [TBL] [Abstract][Full Text] [Related]
14. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment. Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343 [TBL] [Abstract][Full Text] [Related]
15. Treating severe bruxism with botulinum toxin. Tan EK; Jankovic J J Am Dent Assoc; 2000 Feb; 131(2):211-6. PubMed ID: 10680389 [TBL] [Abstract][Full Text] [Related]
16. Clinical investigation of botulinum toxin (prabotulinumtoxin A) for bruxism related to masseter muscle hypertrophy: A prospective study. Jung BK; Park H; Cheon YW; Yun IS; Choi JW; Kim HJ; Lee MY; Kang BS; Kang TJ J Craniomaxillofac Surg; 2023 May; 51(5):332-337. PubMed ID: 37353404 [TBL] [Abstract][Full Text] [Related]
17. A Multicenter Phase II Study Evaluating the Safety and Efficacy of Botulax in Asian Patients with Benign Masseteric Hypertrophy. Lee JS; Son HS; Kim BJ; Lee YW Plast Reconstr Surg; 2024 May; 153(5):910e-918e. PubMed ID: 37335589 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of a Novel Botulinum Toxin A for Masseter Reduction: A Randomized, Double-Blind, Placebo-Controlled, Optimal Dose-Finding Study. Hong JY; Jeong GJ; Kwon TR; Kim JH; Li K; Kim BJ Dermatol Surg; 2021 Jan; 47(1):e5-e9. PubMed ID: 33347002 [TBL] [Abstract][Full Text] [Related]
19. [Botulinum toxin type A treatment of cosmetically disturbing masseteric hypertrophy]. Rijsdijk BA; van ES RJ; Zonneveld FW; Steenks MH; Koole R Ned Tijdschr Geneeskd; 1998 Mar; 142(10):529-32. PubMed ID: 9623101 [TBL] [Abstract][Full Text] [Related]
20. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy. Ahn KY; Kim ST Plast Reconstr Surg; 2007 Nov; 120(6):1662-1666. PubMed ID: 18040203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]